News

Gilead Sciences, Inc. (GILD) Reports Advances in HIV Treatment with Phase 2/3 Clinical Trial Update
Gilead Sciences, Inc. (NASDAQ:GILD) is one of the 10 Best Cheap Stocks to Buy According to Billionaire Ray Dalio.
World’s premier cancer institute faces crippling cuts and chaos
The Trump administration’s broadsides against scientific research have caused unprecedented upheaval at the National Cancer ...
Opinion
FDA should judge drugs on what they do in real life, not just in companies’ clinical trials
Under the new leadership of Marty Makary, the FDA should focus more attention on the critical role of real-world clinical data — such as from health insurance databases — in the ongoing assessment of ...
Study reveals accurate association between weak handgrip and a host of diseases among over-50s
Researchers have provided robust scientific evidence that ailments like depression, high blood pressure, diabetes mellitus, ...
Why Moderna Stock Was So Healthy This Week
The company was pleased to report the findings of a late-stage clinical trial of its advanced flu vaccine. Moderna (NASDAQ: ...
Summit Therapeutics: AstraZeneca Partnership Could Be A Game-Changer, But Clinical Risks Remain
Summit Therapeutics nears a $15B AstraZeneca deal for ivonescimab, targeting a $90B market. See more on the potential and ...
Chamberlain Sun5d
SciatiEase Reviews: Does It Relieve Sciatic Nerve Pain?
Moreover, SciatiEase Reviews frequently highlight inconsistent results: some customers report modest improvements in Sciatic ...
MIRA Reports Potent Inflammatory Pain Relief from Non-Psychoactive Marijuana Analog Mira-55 in Animal Model, Matching Morphine Without Opioid Risks
MIRA is advancing complementary non-opioid therapies for two of the largest pain markets MIAMI, FLORIDA / ACCESS Newswire / ...
Healthline6d
Compounds in Coffee May Help Lower Type 2 Diabetes Risk, Study Finds
A new study reports that people who regularly drink caffeinated and decaffeinated coffee benefit from some of the beverage's ...